Methotrexate is indicated for the treatment of - active rheumatoid arthritis in adult patients, - polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate, Methotrexate self-injectable solution is available as brand-name drugs. It’s not available in a generic form. Brand names: Rasuvo and Otrexup. Preparation of Enbrel. Enbrel is intended for use under the guidance and supervision of a physician. Patients may self-inject when deemed appropriate and if they receive medical follow-up, as necessary. For Rheumatoid Arthritis: I started a low dose of Methotrexate in October and had no changes. In December my Rheum increased my dose and it was like a switch was turned on. Methotrexate (brand name Methoblastin) is a medicine used to treat rheumatoid arthritis as well as other rheumatic conditions such as juvenile arthritis, lupus (also known as SLE), psoriatic arthritis and polymyositis (muscle inflammation). Methotrexate is an immunosuppressive medicine, and reduces inflammation in the joints and associated pain. We offer injection support, whether you are injecting yourself or have a caregiver who is assisting you. We have tools and resources to help you feel confident when giving yourself your dose. Learning to Self Inject Methotrexate at Home Developed by Andy Thompson MD FRCPC and Marie J Craig-Chambers B.Sc.Phm Why might my Doctor ask me to inject Methotrexate? We explain why recording patient safety incidents is important for learning and how to report these incidents. You can also find out how many incidents were recorded and how we use them to support healthcare providers to improve patient safety. Medication Information. The Australian Rheumatology Association (ARA) and Arthritis Australia are pleased to provide the following patient information, for your easy. Methotrexate is contraindicated in pregnancy in women who are being treated for nonmalignant diseases (e.g., psoriasis, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis).